We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Philips Healthcare

Operates in Diagnostic Imaging Systems, Patient Care and Clinical Informatics, Customer Services, and Home Healthcare... read more Featured Products: More products

Download Mobile App




New Transvaginal Transducer Improves Imaging for Gynecology and Early Obstetrics

By HospiMedica International staff writers
Posted on 10 Sep 2026

Transvaginal ultrasound is central to gynecology and early obstetrics, where clinicians must balance deep tissue penetration with high-resolution imaging. More...

Switching probes to achieve this balance can interrupt workflow, lengthen exams, and affect patient comfort. Hospitals also need ergonomic solutions that reduce strain on sonographers without compromising diagnostic confidence. Meeting these clinical and workflow needs, a new lightweight transducer combines enhanced penetration, improved resolution, and a wider field of view in a single device.

Royal Philips has introduced the eV14-2v transvaginal transducer for women’s health ultrasound, designed for a broad range of gynecology and early obstetrics examinations using one probe. The transducer aims to streamline exams and support diagnostic confidence while improving the patient experience.

The eV14-2v delivers enhanced penetration, improved two-dimensional resolution, and a wider field of view in a lightweight, ergonomic design. Compared with the 3D9-3v transducer, it provides a 41.7% increase in penetration, a 10% increase in two-dimensional resolution, a 15.8% wider field of view, and a 22% lighter design.

Built specifically for gynecology and obstetrics imaging, the transducer uses PureWave crystal technology to support detailed visualization of anatomy relevant to infertility assessment and pelvic pain associated with conditions such as endometriosis and fibroids. Its two-dimensional and color resolution also support detection of fetal abnormalities, including delineation of fetal cardiac chambers as early as 13 weeks.

The eV14-2v has received U.S. Food and Drug Administration (FDA) 510(k) clearance and is CE marked. It can be used with Collaboration Live to enable real-time remote consultation during ultrasound exams, allowing clinicians to view live imaging, provide guidance, and consult with care teams without requiring patient travel. This capability can help expand access to specialty care in underserved communities and support more efficient care delivery.

“Reducing transducer changes during exams has a meaningful impact, not just on efficiency, but on the patient experience as well. With the eV14-2v, we’re able to complete more exams with a single transducer while maintaining excellent image quality, which helps streamline our workflow and improve patient comfort,” said Dr. Michael S. Ruma, MD, MPH, Perinatal Associates of New Mexico.


Gold Member
Neonatal Heel Incision Device
Tenderfoot
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Resorbable Bovine Collagen Membrane
GenDerm
Patient Monitoring System
AlarmSense
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Medical Imaging

view channel
Image: A preclinical rabbit model undergoing longitudinal ocular vascular monitoring before and after induced optic nerve injury (upper panel) and a clinical cohort including patients with cervical lymph nodes of different pathological types (bottom panel) were used to demonstrate the generalizability of the framework. The experimental procedures for both studies include ultrasound data acquisition and reconstruction, extraction and analysis of vascular biomarkers, and construction of diagnostic models. The hierarchical edge-bundling diagram (right) illustrates relationships among ocular biomarkers. Each circular leaf node represents a specific biomarker measured in a particular vascular structure. Node size is proportional to the magnitude of the statistically significant difference observed for that biomarker in this study; larger nodes indicate a greater statistically significant difference. (Photo courtesy of XUEJUN Lab@ShanghaiTech)

Automated Platform Converts Super-Resolution Ultrasound into Vascular Biomarkers

Microvascular dysfunction, an early marker of glaucoma, cancer, and other systemic illnesses, often precedes overt clinical signs yet remains difficult to quantify deep in tissue. Super-resolution ultrasound... Read more

Business

view channel
Image: Sempresto’s Smartphone-Integrated Epinephrine Auto-Injector Wins Red Dot Design Award (Photo courtesy of Sempresto)

Smartphone-Integrated Epinephrine Auto-Injector Concept Wins Red Dot Design Award

Severe allergic reactions can escalate rapidly and require prompt epinephrine, yet many at-risk patients do not consistently carry their auto-injector. With food allergies affecting an estimated 220 million... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.